<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28895925</PMID><DateCompleted><Year>2018</Year><Month>05</Month><Day>09</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>9</Issue><PubDate><Year>2017</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Bovine Lactoferrin Inhibits Dengue Virus Infectivity by Interacting with Heparan Sulfate, Low-Density Lipoprotein Receptor, and DC-SIGN.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1957</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms18091957</ELocationID><Abstract><AbstractText>Bovine lactoferrin (bLF) presents in milk and has been shown to inhibit several viral infections. Effective drugs are unavailable for the treatment of dengue virus (DENV) infection. In this study, we evaluated the antiviral effect of bLF against DENV infection in vivo and in vitro. Bovine LF significantly inhibited the infection of the four serotypes of DENV in Vero cells. In the time-of-drug addition test, DENV-2 infection was remarkably inhibited when bLF was added during or prior to the occurrence of virus attachment. We also revealed that bovine LF blocks binding between DENV-2 and the cellular membrane by interacting with heparan sulfate (HS), dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN), and low-density lipoprotein receptors (LDLR). In addition, bLF inhibits DENV-2 infection and decreases morbidity in a suckling mouse challenge model. This study supports the finding that bLF may inhibit DENV infection by binding to the potential DENV receptors.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jo-Mei</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung Hsing University, Taichung 40227, Taiwan. chenjm0317@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Yi-Chin</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung Hsing University, Taichung 40227, Taiwan. yichinfan0309@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jen-Wei</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung Hsing University, Taichung 40227, Taiwan. provista.wei@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yi-Ying</ForeName><Initials>YY</Initials><AffiliationInfo><Affiliation>Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung Hsing University, Taichung 40227, Taiwan. irisgf1986@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Wei-Li</ForeName><Initials>WL</Initials><AffiliationInfo><Affiliation>Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung Hsing University, Taichung 40227, Taiwan. wlhsu@dragon.nchu.edu.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiou</LastName><ForeName>Shyan-Song</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung Hsing University, Taichung 40227, Taiwan. sschiou@dragon.nchu.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015815">Cell Adhesion Molecules</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C405948">DC-specific ICAM-3 grabbing nonintegrin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037181">Lectins, C-Type</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011956">Receptors, Cell Surface</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011973">Receptors, LDL</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011991">Receptors, Virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C111476">dengue virus receptor</NameOfSubstance></Chemical><Chemical><RegistryNumber>9050-30-0</RegistryNumber><NameOfSubstance UI="D006497">Heparitin Sulfate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.21.-</RegistryNumber><NameOfSubstance UI="D007781">Lactoferrin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002417" MajorTopicYN="N">Cattle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015815" MajorTopicYN="N">Cell Adhesion Molecules</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006497" MajorTopicYN="N">Heparitin Sulfate</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020128" MajorTopicYN="N">Inhibitory Concentration 50</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007781" MajorTopicYN="N">Lactoferrin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D037181" MajorTopicYN="N">Lectins, C-Type</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011956" MajorTopicYN="N">Receptors, Cell Surface</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011973" MajorTopicYN="N">Receptors, LDL</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011991" MajorTopicYN="N">Receptors, Virus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000074084" MajorTopicYN="N">THP-1 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010948" MajorTopicYN="N">Viral Plaque Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053585" MajorTopicYN="N">Virus Attachment</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DC-SIGN</Keyword><Keyword MajorTopicYN="N">bovine lactoferrin</Keyword><Keyword MajorTopicYN="N">dengue virus</Keyword><Keyword MajorTopicYN="N">heparan sulfate</Keyword><Keyword MajorTopicYN="N">low-density lipoprotein receptor</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28895925</ArticleId><ArticleId IdType="pmc">PMC5618606</ArticleId><ArticleId IdType="doi">10.3390/ijms18091957</ArticleId><ArticleId IdType="pii">ijms18091957</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Van der Strate B.W., Beljaars L., Molema G., Harmsen M.C., Meijer D.K. Antiviral activities of lactoferrin. Antivir. Res. 2001;52:225&#x2013;239. doi: 10.1016/S0166-3542(01)00195-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0166-3542(01)00195-4</ArticleId><ArticleId IdType="pubmed">11675140</ArticleId></ArticleIdList></Reference><Reference><Citation>Lonnerdal B., Iyer S. Lactoferrin: Molecular structure and biological function. Annu. Rev. Nutr. 1995;15:93&#x2013;110. doi: 10.1146/annurev.nu.15.070195.000521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.nu.15.070195.000521</ArticleId><ArticleId IdType="pubmed">8527233</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng T.Y., Chen L.C., Shyu H.W., Chen S.H., Wang J.R., Yu C.K., Lei H.Y., Yeh T.M. Lactoferrin inhibits enterovirus 71 infection by binding to vp1 protein and host cells. Antivir. Res. 2005;67:31&#x2013;37. doi: 10.1016/j.antiviral.2005.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2005.03.005</ArticleId><ArticleId IdType="pubmed">15916817</ArticleId></ArticleIdList></Reference><Reference><Citation>Beleid R., Douglas D., Kneteman N., Kaur K. Helical peptides derived from lactoferrin bind hepatitis c virus envelope protein e2. Chem. Biol. Drug Des. 2008;72:436&#x2013;443. doi: 10.1111/j.1747-0285.2008.00715.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1747-0285.2008.00715.x</ArticleId><ArticleId IdType="pubmed">19012577</ArticleId></ArticleIdList></Reference><Reference><Citation>El Yazidi-Belkoura I., Legrand D., Nuijens J., Slomianny M.C., van Berkel P., Spik G. The binding of lactoferrin to glycosaminoglycans on enterocyte-like HT29&#x2013;18-C1 cells is mediated through basic residues located in the N-terminus. Biochim. Biophys. Acta. 2001;1568:197&#x2013;204. doi: 10.1016/S0304-4165(01)00222-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-4165(01)00222-7</ArticleId><ArticleId IdType="pubmed">11786226</ArticleId></ArticleIdList></Reference><Reference><Citation>Chien Y.J., Chen W.J., Hsu W.L., Chiou S.S. Bovine lactoferrin inhibits japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein. Virology. 2008;379:143&#x2013;151. doi: 10.1016/j.virol.2008.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2008.06.017</ArticleId><ArticleId IdType="pubmed">18640695</ArticleId></ArticleIdList></Reference><Reference><Citation>Groot F., Geijtenbeek T.B., Sanders R.W., Baldwin C.E., Sanchez-Hernandez M., Floris R., van Kooyk Y., de Jong E.C., Berkhout B. Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the Dc-SIGN&#x2014;gp120 interaction. J. Virol. 2005;79:3009&#x2013;3015. doi: 10.1128/JVI.79.5.3009-3015.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.5.3009-3015.2005</ArticleId><ArticleId IdType="pmc">PMC548463</ArticleId><ArticleId IdType="pubmed">15709021</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead S.B. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: A pathogenetic cascade. Rev. Infect. Dis. 1989;11(Suppl. S4):S830&#x2013;S839. doi: 10.1093/clinids/11.Supplement_4.S830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/11.Supplement_4.S830</ArticleId><ArticleId IdType="pubmed">2665015</ArticleId></ArticleIdList></Reference><Reference><Citation>Henchal E.A., Putnak J.R. The dengue viruses. Clin. Microbiol. Rev. 1990;3:376&#x2013;396. doi: 10.1128/CMR.3.4.376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.3.4.376</ArticleId><ArticleId IdType="pmc">PMC358169</ArticleId><ArticleId IdType="pubmed">2224837</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung S.L., Lee P.L., Chen H.W., Chen L.K., Kao C.L., King C.C. Analysis of the steps involved in dengue virus entry into host cells. Virology. 1999;257:156&#x2013;167. doi: 10.1006/viro.1999.9633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1999.9633</ArticleId><ArticleId IdType="pubmed">10208929</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Maguire T., Hileman R.E., Fromm J.R., Esko J.D., Linhardt R.J., Marks R.M. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 1997;3:866&#x2013;871. doi: 10.1038/nm0897-866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0897-866</ArticleId><ArticleId IdType="pubmed">9256277</ArticleId></ArticleIdList></Reference><Reference><Citation>Tassaneetrithep B., Burgess T.H., Granelli-Piperno A., Trumpfheller C., Finke J., Sun W., Eller M.A., Pattanapanyasat K., Sarasombath S., Birx D.L., et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 2003;197:823&#x2013;829. doi: 10.1084/jem.20021840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20021840</ArticleId><ArticleId IdType="pmc">PMC2193896</ArticleId><ArticleId IdType="pubmed">12682107</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozach P.Y., Burleigh L., Staropoli I., Navarro-Sanchez E., Harriague J., Virelizier J.L., Rey F.A., Despres P., Arenzana-Seisdedos F., Amara A. Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals. J. Biol. Chem. 2005;280:23698&#x2013;23708. doi: 10.1074/jbc.M504337200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M504337200</ArticleId><ArticleId IdType="pubmed">15855154</ArticleId></ArticleIdList></Reference><Reference><Citation>Alen M.M., Kaptein S.J., De Burghgraeve T., Balzarini J., Neyts J., Schols D. Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection. Virology. 2009;387:67&#x2013;75. doi: 10.1016/j.virol.2009.01.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2009.01.043</ArticleId><ArticleId IdType="pubmed">19264337</ArticleId></ArticleIdList></Reference><Reference><Citation>Alen M.M., De Burghgraeve T., Kaptein S.J., Balzarini J., Neyts J., Schols D. Broad antiviral activity of carbohydrate-binding agents against the four serotypes of dengue virus in monocyte-derived dendritic cells. PLoS ONE. 2011;6:e21658. doi: 10.1371/journal.pone.0021658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0021658</ArticleId><ArticleId IdType="pmc">PMC3128091</ArticleId><ArticleId IdType="pubmed">21738755</ArticleId></ArticleIdList></Reference><Reference><Citation>Waarts B.L., Aneke O.J., Smit J.M., Kimata K., Bittman R., Meijer D.K., Wilschut J. Antiviral activity of human lactoferrin: Inhibition of alphavirus interaction with heparan sulfate. Virology. 2005;333:284&#x2013;292. doi: 10.1016/j.virol.2005.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2005.01.010</ArticleId><ArticleId IdType="pubmed">15721362</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho C.A.M., Casseb S.M.M., Goncalves R.B., Silva E.V.P., Gomes A.M.O., Vasconcelos P.F.C. Bovine lactoferrin activity against chikungunya and zika viruses. J. Gen. Virol. 2017 doi: 10.1099/jgv.0.000849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000849</ArticleId><ArticleId IdType="pubmed">28699858</ArticleId></ArticleIdList></Reference><Reference><Citation>Huettinger M., Meilinger M., Gschwentner C., Lassmann H. The LDL-receptor family. Lactoferrin and lipid metabolism. Adv. Exp. Med. Biol. 1998;443:107&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pubmed">9781349</ArticleId></ArticleIdList></Reference><Reference><Citation>Berges C., Naujokat C., Tinapp S., Wieczorek H., Hoh A., Sadeghi M., Opelz G., Daniel V. A cell line model for the differentiation of human dendritic cells. Biochemic. Biophys. Res. Commun. 2005;333:896&#x2013;907. doi: 10.1016/j.bbrc.2005.05.171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2005.05.171</ArticleId><ArticleId IdType="pubmed">15963458</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P.C., Liao M.Y., Cheng P.C., Liang J.J., Liu I.J., Chiu C.Y., Lin Y.L., Chang G.J., Wu H.C. Development of a humanized antibody with high therapeutic potential against dengue virus type 2. PLoS Negl. Trop. Dis. 2012;6:e1636. doi: 10.1371/journal.pntd.0001636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001636</ArticleId><ArticleId IdType="pmc">PMC3341331</ArticleId><ArticleId IdType="pubmed">22563515</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetti M., Superti F., Ammendolia M.G., Rossi P., Valenti P., Seganti L. Inhibition of poliovirus type 1 infection by iron-, manganese- and zinc-saturated lactoferrin. Med. Microbiol. Immunol. 1999;187:199&#x2013;204. doi: 10.1007/s004300050093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004300050093</ArticleId><ArticleId IdType="pubmed">10363676</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietrantoni A., Ammendolia M.G., Tinari A., Siciliano R., Valenti P., Superti F. Bovine lactoferrin peptidic fragments involved in inhibition of echovirus 6 in vitro infection. Antivir. Res. 2006;69:98&#x2013;106. doi: 10.1016/j.antiviral.2005.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2005.10.006</ArticleId><ArticleId IdType="pubmed">16386316</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara K., Ikeda M., Saito S., Matsumoto S., Numata K., Kato N., Tanaka K., Sekihara H. Lactoferrin inhibits hepatitis b virus infection in cultured human hepatocytes. Hepatol. Res. 2002;24:228. doi: 10.1016/S1386-6346(02)00088-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1386-6346(02)00088-8</ArticleId><ArticleId IdType="pubmed">12393024</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietrantoni A., Fortuna C., Remoli M.E., Ciufolini M.G., Superti F. Bovine lactoferrin inhibits toscana virus infection by binding to heparan sulphate. Viruses. 2015;7:480&#x2013;495. doi: 10.3390/v7020480.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7020480</ArticleId><ArticleId IdType="pmc">PMC4353899</ArticleId><ArticleId IdType="pubmed">25643293</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanyshkova T.G., Babina S.E., Semenov D.V., Isaeva N., Vlassov A.V., Neustroev K.N., Kul&#x2019;minskaya A.A., Buneva V.N., Nevinsky G.A. Multiple enzymic activities of human milk lactoferrin. Eur. J. Biochem. 2003;270:3353&#x2013;3361. doi: 10.1046/j.1432-1033.2003.03715.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1432-1033.2003.03715.x</ArticleId><ArticleId IdType="pubmed">12899692</ArticleId></ArticleIdList></Reference><Reference><Citation>Zemankova N., Chlebova K., Matiasovic J., Prodelalova J., Gebauer J., Faldyna M. Bovine lactoferrin free of lipopolysaccharide can induce a proinflammatory response of macrophages. BMC Vet. Res. 2016;12:251. doi: 10.1186/s12917-016-0878-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12917-016-0878-2</ArticleId><ArticleId IdType="pmc">PMC5103330</ArticleId><ArticleId IdType="pubmed">27829421</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilgard P., Stockert R. Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes. Hepatology. 2000;32:1069&#x2013;1077. doi: 10.1053/jhep.2000.18713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jhep.2000.18713</ArticleId><ArticleId IdType="pubmed">11050058</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H.F., Monroe D.M., Church F.C. Characterization of the glycosaminoglycan-binding region of lactoferrin. Arch. Biochem. Biophys. 1995;317:85&#x2013;92. doi: 10.1006/abbi.1995.1139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/abbi.1995.1139</ArticleId><ArticleId IdType="pubmed">7872808</ArticleId></ArticleIdList></Reference><Reference><Citation>Agnello V., Abel G., Elfahal M., Knight G.B., Zhang Q.X. Hepatitis c virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA. 1999;96:12766&#x2013;12771. doi: 10.1073/pnas.96.22.12766.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.22.12766</ArticleId><ArticleId IdType="pmc">PMC23090</ArticleId><ArticleId IdType="pubmed">10535997</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto-Acosta R., Mosso C., Cervantes-Salazar M., Puerta-Guardo H., Medina F., Favari L., Ludert J.E., del Angel R.M. The increase in cholesterol levels at early stages after dengue virus infection correlates with an augment in ldl particle uptake and hmg-coa reductase activity. Virology. 2013;442:132&#x2013;147. doi: 10.1016/j.virol.2013.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2013.04.003</ArticleId><ArticleId IdType="pubmed">23642566</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagar Z.L., Tree M.O., Mpoy M.C., Conway M.J. Low density lipopolyprotein inhibits flavivirus acquisition in aedes aegypti. Insect. Mol. Biol. 2017 doi: 10.1111/imb.12334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imb.12334</ArticleId><ArticleId IdType="pubmed">28718976</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr A.G., Tam L.C.S., Hale A.B., Cioroch M., Douglas G., Agkatsev S., Hibbitt O., Mason J., Holt-Martyn J., Bataille C.J.R., et al. A genomic DNA reporter screen identifies squalene synthase inhibitors that act cooperatively with statins to upregulate the low-density lipoprotein receptor. J. Pharmacol. Exp. Ther. 2017;361:417&#x2013;428. doi: 10.1124/jpet.116.239574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.116.239574</ArticleId><ArticleId IdType="pmc">PMC5443320</ArticleId><ArticleId IdType="pubmed">28360334</ArticleId></ArticleIdList></Reference><Reference><Citation>Jindadamrongwech S., Smith D.R. Virus overlay protein binding assay (vopba) reveals serotype specific heterogeneity of dengue virus binding proteins on hepg2 human liver cells. Intervirology. 2004;47:370&#x2013;373. doi: 10.1159/000080882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000080882</ArticleId><ArticleId IdType="pubmed">15564750</ArticleId></ArticleIdList></Reference><Reference><Citation>Thepparit C., Smith D.R. Serotype-specific entry of dengue virus into liver cells: Identification of the 37-kilodalton/67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptor. J. Virol. 2004;78:12647&#x2013;12656. doi: 10.1128/JVI.78.22.12647-12656.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.22.12647-12656.2004</ArticleId><ArticleId IdType="pmc">PMC525075</ArticleId><ArticleId IdType="pubmed">15507651</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuller A., Yin Z., Brian Chia C.S., Doan D.N., Kim H.K., Shang L., Loh T.P., Hill J., Vasudevan S.G. Tripeptide inhibitors of dengue and west nile virus NS2B-NS3 protease. Antivir. Res. 2011;92:96&#x2013;101. doi: 10.1016/j.antiviral.2011.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2011.07.002</ArticleId><ArticleId IdType="pubmed">21763725</ArticleId></ArticleIdList></Reference><Reference><Citation>Harada E., Itoh Y., Sitizyo K., Takeuchi T., Araki Y., Kitagawa H. Characteristic transport of lactoferrin from the intestinal lumen into the bile via the blood in piglets. Comp. Biochem. Physiol. Mol. Integr. Physiol. 1999;124:321&#x2013;327. doi: 10.1016/S1095-6433(99)00122-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1095-6433(99)00122-1</ArticleId><ArticleId IdType="pubmed">10665381</ArticleId></ArticleIdList></Reference><Reference><Citation>Picard-Jean F., Bouchard S., Larivee G., Bisaillon M. The intracellular inhibition of HCV replication represents a novel mechanism of action by the innate immune lactoferrin protein. Antivir. Res. 2014;111:13&#x2013;22. doi: 10.1016/j.antiviral.2014.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2014.08.012</ArticleId><ArticleId IdType="pubmed">25193851</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>